Article Details

Equities Analysts Issue Forecasts for Ocular Therapeutix, Inc.'s Q2 2022 Earnings (NASDAQ:OCUL)

Retrieved on: 2022-06-03 11:27:04

Tags for this article:

Click the tags to see associated articles and topics

Equities Analysts Issue Forecasts for Ocular Therapeutix, Inc.'s Q2 2022 Earnings (NASDAQ:OCUL). View article details on hiswai:

Excerpt

BlackRock Inc. now owns 5,122,835 shares of the biopharmaceutical company's stock worth $35,706,000 after acquiring an additional 150,777 shares ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up